drugset / Trial / NCT00244725

Odiparcil For The Prevention Of Venous Thromboembolism

NCT00244725

Phase 2 Completed 961 enrolled GlaxoSmithKline
RandomizedSingle-groupDouble-blindPrevention

Summary

Odiparcil is being studied to determine if it can prevent blood clots from forming after a total knee replacement and also to prove that odiparcil is safe.

Timeline

Start
2005-09
Primary completion
2006-09
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Odiparcil Small molecule
Subject Warfarin Small molecule